Deletion of the CIS gene enhances the responsiveness of NK cells to IL-15, thereby promoting their proliferation and survival, increasing IFN-γ secretion, and boosting antitumor cytotoxic activity, ultimately improving the suppression of tumor metastasis [108]. This evidence concerns the gene IL15 and in situ carcinoma.